Japan Prospective Long Term Clinical Trial in Type 2 Diabetes Patients with Sulfonyl Urea and Sitagliptin
Phase of Trial: Phase III
Latest Information Update: 13 May 2016
At a glance
- Drugs Sitagliptin (Primary) ; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms J-PLUS
- 09 Apr 2016 Status changed from active, no longer recruiting to completed.
- 11 Apr 2015 Planned End Date changed from 1 Oct 2014 to 5 Dec 2014 as reported by University Hospital Medical Information Network - Japan record.
- 11 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.